Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells
Coralie Hoareau-Aveilla, Cathy Quelen, Annabelle Congras, Nina Caillet, Delphine Labourdette, Christine Dozier, Pierre Brousset, Laurence Lamant, Fabienne Meggetto
Haematologica February 2019 104: 347-359; doi:10.3324/haematol.2018.195131
Coralie Hoareau-Aveilla
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cathy Quelen
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annabelle Congras
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nina Caillet
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Delphine Labourdette
Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Dozier
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Brousset
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France European Research Initiative on ALK-Related Malignancies, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Lamant
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France European Research Initiative on ALK-Related Malignancies, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabienne Meggetto
Inserm, UMR1037 CRCT, F-31000 Toulouse, France Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France CNRS, ERL5294 CRCT, F-31000 Toulouse, France Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France European Research Initiative on ALK-Related Malignancies, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fabienne.meggetto@inserm.fr

Author Affiliations

  1. Coralie Hoareau-Aveilla1,2,3,*,
  2. Cathy Quelen1,2,3,*,
  3. Annabelle Congras1,2,3,§,
  4. Nina Caillet1,2,3,§,
  5. Delphine Labourdette4,
  6. Christine Dozier1,2,3,
  7. Pierre Brousset1,2,3,5,6,7,§,
  8. Laurence Lamant1,2,3,5,6,7,§ and
  9. Fabienne Meggetto1,2,3,5,6,7,§⇑
  1. 1Inserm, UMR1037 CRCT, F-31000 Toulouse, France
  2. 2Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France
  3. 3CNRS, ERL5294 CRCT, F-31000 Toulouse, France
  4. 4Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France
  5. 5Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France
  6. 6Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France
  7. 7European Research Initiative on ALK-Related Malignancies, Cambridge, UK
  1. Correspondence:
    fabienne.meggetto{at}inserm.fr
View Abstract
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 104 no. 2 347-359
DOI 
https://doi.org/10.3324/haematol.2018.195131
PubMed 
30262555

Published By 
Haematologica
Print ISSN 
0390-6078
Online ISSN 
1592-8721

History 
  • Received April 9, 2018
  • Accepted September 21, 2018

Article Versions

  • previous version (September 27, 2018 - 03:57).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2019 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions:https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.

Author Information

  1. Coralie Hoareau-Aveilla1,2,3,*,
  2. Cathy Quelen1,2,3,*,
  3. Annabelle Congras1,2,3,§,
  4. Nina Caillet1,2,3,§,
  5. Delphine Labourdette4,
  6. Christine Dozier1,2,3,
  7. Pierre Brousset1,2,3,5,6,7,§,
  8. Laurence Lamant1,2,3,5,6,7,§ and
  9. Fabienne Meggetto1,2,3,5,6,7,§⇑
  1. 1Inserm, UMR1037 CRCT, F-31000 Toulouse, France
  2. 2Université Toulouse III-Paul Sabatier, UMR1037 CRCT, F-31000 Toulouse, France
  3. 3CNRS, ERL5294 CRCT, F-31000 Toulouse, France
  4. 4Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France
  5. 5Institut Carnot Lymphome-CALYM, F-31024 Toulouse, France
  6. 6Laboratoire d’Excellence Toulouse Cancer-TOUCAN, F-31024 Toulouse, France
  7. 7European Research Initiative on ALK-Related Malignancies, Cambridge, UK
  1. Correspondence:
    fabienne.meggetto{at}inserm.fr
View Abstract

Statistics from Altmetric.com

Article usage

Article usage: September 2018 to January 2019

AbstractFullPdf
Sep 20181301
Oct 2018125064
Nov 201843020
Dec 201825010
Jan 201985424
PreviousNext
Back to top

Vol 104 Issue 2

Haematologica: 104 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word about Haematologica.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells
(Your Name) has forwarded a page to you from Haematologica
(Your Name) thought you would like to see this page from the Haematologica web site.
Print
Citation Tools
miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells
Coralie Hoareau-Aveilla, Cathy Quelen, Annabelle Congras, Nina Caillet, Delphine Labourdette, Christine Dozier, Pierre Brousset, Laurence Lamant, Fabienne Meggetto
Haematologica Feb 2019, 104 (2) 347-359; DOI: 10.3324/haematol.2018.195131

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Coralie Hoareau-Aveilla, Cathy Quelen, Annabelle Congras, Nina Caillet, Delphine Labourdette, Christine Dozier, Pierre Brousset, Laurence Lamant, Fabienne Meggetto
Haematologica Feb 2019, 104 (2) 347-359; DOI: 10.3324/haematol.2018.195131
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Alert me when this article is cited
  • Alert me if a correction is posted

Jump To

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

More in this TOC Section

Article

  • Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy
  • Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia
Show more Article

Non-Hodgkin Lymphoma

  • Burkitt-like lymphoma with 11q aberration: A germinal center derived lymphoma genetically unrelated to Burkitt lymphoma
  • The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity than SAR3419 in CD19-positive lymphoma and leukemia models
Show more Non-Hodgkin Lymphoma

Related Articles

Cited By...

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online